HIF1A and hepatocellular carcinoma: The results showed that compared with the control group, the migration ability of cells was decreased after treatment with ASP or HIF-1α RNAi alone, and the effect was similar in both groups, indicating that ASP or HIF-1α RNAi could affect the migration ability of HCC cells.